Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany people find their appetite drops so sharply on tirzepatide that they naturally eat far less — and some wonder whether adding deliberate fasting could push results further. The honest answer is that fasting and Mounjaro interact in ways that are worth understanding before you experiment. Mounjaro (tirzepatide) is a prescription-only medicine; a prescriber, not a fasting protocol, decides what is safe and appropriate for you personally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity to tirzepatide or placebo alongside a structured lifestyle programme: a modest calorie deficit of around 500 kcal per day, plus increased physical activity. At 15 mg, participants lost an average of around 20–21% of body weight over 72 weeks. That result was built on consistent, sustainable eating, not on skipping meals or time-restricted windows.
This matters because it is easy to assume the medicine does more if you eat less. The evidence does not support that assumption in any straightforward way. Tirzepatide works by slowing gastric emptying, reducing appetite signals from the gut and brain, and improving how the body handles blood sugar. It is already doing a great deal of the metabolic work. Adding aggressive fasting on top is not a studied combination, and the official guidance (including NHS England's weight-management-injections resource) emphasises a nutritionally adequate diet alongside treatment, not restriction for its own sake.
If you are curious about what to eat day-to-day on Mounjaro, the food and diet guidance on this site covers practical approaches in much more detail.
There is a misconception worth addressing gently here: that because Mounjaro suppresses appetite so effectively, you can simply stop eating and the medicine will carry you through. It does not work that way, and it can backfire.
The most common side effects of tirzepatide are gastrointestinal (nausea, reflux, fatigue, dizziness) and they are most pronounced after starting treatment or stepping up a dose. Going too long between meals on an already unsettled stomach tends to make nausea worse, not better. Dizziness can also intensify if you are in a fasted state and your blood sugar dips lower than usual, especially in the early titration weeks at 2.5 mg or 5 mg.
There is also a nutritional concern. Because appetite falls sharply, people on tirzepatide are already eating significantly less. Layering deliberate fasting on top risks inadequate protein intake, which matters for preserving muscle mass during weight loss, something the NHS Live Well healthy weight guidance consistently highlights. Hydration deserves attention too: fasting periods often reduce fluid intake at exactly the point when the GI effects of the medicine make dehydration more likely.
Extended water fasting carries its own set of considerations when combined with a GLP-1 medicine. Our page on water fasting on Mounjaro goes into that specific scenario in more depth.
Mounjaro is injected once a week, so it does not have the meal-timing dependency that some daily medicines do. There is no requirement to eat immediately before or after your injection. That gives genuine flexibility over when you eat each day, and some people find they naturally fall into a pattern of eating within a shorter window, not because they are deliberately fasting, but because appetite suppression means they simply are not hungry at the times they used to eat.
That kind of organic, appetite-led eating rhythm is very different from structured intermittent fasting protocols. If you are thinking about the latter (16:8, 5:2, or anything more extended) the prudent approach is to raise it with your prescriber before making changes. They can consider your current dose, your tolerance so far, and any other health factors that bear on the question. Fasting on tirzepatide is a reasonable topic to bring to a clinical review; it is not one to resolve based on a forum post.
For a broader look at how tirzepatide interacts with different dietary approaches, the fasting on tirzepatide page covers the mechanism in more detail, and eating normally on Mounjaro addresses the everyday practical question many people have at the start of treatment.
If you are still working out whether Mounjaro is the right medicine for you, our Mounjaro overview sets out what is known about the medicine, how treatment works, and what clinical assessment involves. A note on cost: treatment pricing is transparent and all-inclusive at nume; the Mounjaro prices page explains what that covers. When you are ready to speak with a clinician, starting a free consultation is the straightforward next step, a GPhC-registered prescriber reviews your answers personally and can talk through any dietary questions you have.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.